About the Project
SPARC (Support of Personalized Medicine Approaches in Cancer) is a three-year EU4Health project advancing equitable and sustainable personalised cancer medicine across Europe. By uniting hospitals, universities, research institutions, and patient organisations, SPARC builds the framework for implementing personalised medicine into real-world healthcare systems, ensuring that scientific innovation translates into tangible benefits for all patients.
Project Objectives
SPARC’s objectives are structured around six interlinked pillars representing its holistic approach to personalised oncology:
- Evidence and Standardisation - SPARC develops validated, harmonised protocols for NGS and liquid biopsy to ensure reproducible and interoperable diagnostics across Member States. Evidence collected from seven cancer pilots feeds into consensus-based guidelines for clinical use.
- Clinical Integration through Molecular Tumour Boards (MTBs) - By establishing MTBs in pilot centres, SPARC enhances multidisciplinary decision-making and ensures that molecular findings are meaningfully translated into patient care.
- Digital and AI-Driven Tools - The project reviews and specifies digital tools that enable data integration, tele-oncology, and AI-assisted interpretation, facilitating seamless collaboration between researchers, clinicians, and patients while maintaining full GDPR compliance.
- Training, Certification, and Capacity Building - SPARC delivers comprehensive education programmes for healthcare professionals from introductory molecular oncology to expert-level modules in liquid biopsy and MTB practice alongside certification schemes ensuring standardised competencies across Europe.
- Patient Engagement and Empowerment - Patient organisations co-create training and communication materials to enhance literacy in personalised medicine. Patients and citizens participate in advisory committees, contributing directly to pilot design, evaluation, and policy outcomes.
- Equity, Sustainability, and Policy Impact - Through evidence-based mapping, SPARC identifies inequities in access to personalised medicine and formulates policy recommendations and sustainable business models for equitable implementation across EU healthcare systems.
SIOPE’s Role in the Project
Within SPARC, SIOPE works to ensure that the unique needs and perspectives of paediatric cancer patients and their families are included in the development of personalized cancer medicine.
SIOPE is actively supports in several Work Packages, namely WP4 (Pilots on Molecular Tumor Boards and Tools), WP5 (Digital Tools Supporting Precision Cancer Oncology), WP7 (Patient and Stakeholder Engagement), WP8 (Addressing Inequalities and Shaping Policy), and WP9 (Dissemination and Communication). For more information about the SPARC project, please visit its dedicated website.